Device Trial Radar · NCT05317858
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
96
Planned (sponsor's estimate)
Start
Aug 12, 2022
Primary completion
Jun 1, 2031
Study completion Dec 1, 2031
Sponsor
- Lead sponsor
- InSightecNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 8, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier opening with Exablate Model 4000 Type 2.0/2.1 for the treatment of NSCLC brain metastases in patients who are undergoing planned FDA approved, on-label systemic therapy utilizing immune checkpoint inhibitors.
Conditions
- Brain Tumor
- Non Small Cell Lung Cancer
Interventions
Blood Brain Barrier Opening - OncologyDevice
BBB opening via Exablate Type 2 system with microbubble resonators on the day of ICI infusion to treat brain metastases.
PembrolizumabDrug
Pembrolizumab infusion
AtezolizumabDrug
Atezolizumab infusion
CemiplimabDrug
Cemiplimab infusion
NivolumabDrug
Nivolumab infusion
IptilimumabDrug
Iptilimumab infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventsTime frame: up to 6 months
- tumor lesion(s) on the MRI imagesTime frame: up to 6 months
Locations
16 sites in 3 countries. Site status is shown where the registry gives one.
St. Joseph's Hospital and Medical Center
Phoenix, Arizona · Withdrawn
Hoag Memorial Hospital Presbyterian
Newport Beach, California · Recruiting
Broward Health
Fort Lauderdale, Florida · Recruiting
13 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.